March 29, 2023
The Ministry of Health, Labor and Welfare (MHLW) on March 27 granted orphan drug designation for four APIs including Ipsen’s fidrisertib and Chugai Pharmaceutical’s faricimab. Fidrisertib was designated for the treatment of fibrodysplasia ossificans progressiva, while faricimab earned the status...read more